Clinical Trials for BioGene Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BioGene Therapeutics

Clinical Trials (3)

NCT06705725
Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma
PHASE1Not yet recruiting
38 participants
Started: Dec 26, 2024 · Completed: Feb 22, 2028
1 condition1 sponsor0 locations
NCT06461624
Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
PHASE1Recruiting
15 participants
Started: Jul 1, 2024 · Completed: Oct 31, 2027
1 condition2 sponsors2 locations
NCT04803929
Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
EARLY_PHASE1Recruiting
25 participants
Started: Mar 3, 2021 · Completed: Mar 1, 2026
2 conditions2 sponsors1 location